2025年4月16日，歐盟食品安全局（EFSA）發布消息，歐盟食品安全局發布關于釀酒酵母NCYC R404作為奶牛飼料添加劑的授權更新申請的評估。
經過評估，專家小組得出結論，該添加劑在授權使用條件下對目標物種、消費者和環境都是安全的。在授權更新的情況下，無需評估添加劑的功效。部分原文報道如下：
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of the authorisation of Saccharomyces cerevisiae NCYC R404 as a zootechnical additive (functional group: gut flora stabilisers) for dairy cows. The applicant has provided evidence that the additive currently on the market complies with the existing conditions of authorisation. There was no new evidence that would lead the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) to reconsider its previous conclusions on the safety of the product for the target species, consumers and the environment, for which the additive is considered to remain safe. Regarding user safety, the Panel reiterates its previous conclusions that the additive is not irritant to eyes and skin but should be considered a potential skin and respiratory sensitiser, and any exposure through skin and respiratory tract is considered a risk. There is no need for assessing the efficacy of the additive in the context of renewal of the authorisation.
經過評估，專家小組得出結論，該添加劑在授權使用條件下對目標物種、消費者和環境都是安全的。在授權更新的情況下，無需評估添加劑的功效。部分原文報道如下：
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of the authorisation of Saccharomyces cerevisiae NCYC R404 as a zootechnical additive (functional group: gut flora stabilisers) for dairy cows. The applicant has provided evidence that the additive currently on the market complies with the existing conditions of authorisation. There was no new evidence that would lead the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) to reconsider its previous conclusions on the safety of the product for the target species, consumers and the environment, for which the additive is considered to remain safe. Regarding user safety, the Panel reiterates its previous conclusions that the additive is not irritant to eyes and skin but should be considered a potential skin and respiratory sensitiser, and any exposure through skin and respiratory tract is considered a risk. There is no need for assessing the efficacy of the additive in the context of renewal of the authorisation.
